Powered by Abbott's Libre Sense Glucose Sport Biosensor, Supersapiens offers truly meaningful fuel data through continuous glucose visibility.
Supersapiens is a sports performance brand focused on energy management systems that empower athletes to go faster longer. Utilizing pioneering biosensing technology, the Abbott Libre Sense Glucose Sport Biosensor, with the Supersapiens app, enables you to conveniently see your body’s molecular glucose data in real time.
The small device worn on the back of the upper arm uses a thin, flexible filament inserted just under the skin to accurately detect glucose levels inside the body from the interstitial fluid - a thin layer of fluid surrounding the cells of the tissues just below your skin. The glucose biosensor is designed to adhere to the back of the upper arm and provide accurate glucose readings for up to 14 days. The biosensor can be worn while bathing, showering, swimming or exercise.
What do you need the data for? Use your live glucose data to appropriately refuel and keep your glucose levels above 70. This promotes glycogen replenishment and muscle protein synthesis after workouts and helps get you ready for the next training session. Use your minute-by-minute glucose data to help keep your glucose levels under 140. Reduce steep glucose spikes that can lead to inflammation. Use your real-time glucose data to make informed nutrition decisions between workouts to keep your glucose levels within the optimal Glucose Recovery Zone. Use your Trailing Average Glucose to see if you are sufficiently carbohydrate loading.
Thus you know exactly when to fuel to maintain your energy and physical and mental performance. Innovative insights empower you to calibrate your own personal nutrition strategy so you can take the guesswork out of fueling. This is why the sensor has been widely adopted by elite and non-elite athletes across a range of sports.
Founder and CEO of Supersapiens, Phil Southerland was diagnosed with Type 1 diabetes when he was 7 months old. He was expected to be blind or dead by 25.
Growing up, he realized exercise enabled him to manage the disease and that glucose control led to success in sports. Teaming up with Abbott in 2006, Phil used their continuous glucose monitor (CGM) in the Race Across America. His all type 1 diabetic team finished second place on their first attempt; the following year, armed with a better understanding of glucose management, they won the race and set a new world record time.
Phil has been working with Abbott to pioneer CGM for the past 16 years. And when he linked CGM data to head units in 2018, Phil experienced the a-ha moment, connecting real-time glucose levels and exercise performance. Phil knew the value of this data was not just for people with diabetes, but for every athlete, and every human who needs energy striving to become a better version of themselves. And that is why we invested in Supersapiens.
